Stock Analysis
Encompass Health Corporation (EHC) Stock Analysis
Encompass Health Corporation (EHC) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Encompass Health Corporation (EHC) currently has an AIQ Score of 62/100, indicating a neutral setup. Quality is the strongest factor at 69/100. Value is the weakest current factor at 57/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
EHC at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $121.79 |
| AIQ Score | 62/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Buy |
| Market Cap | $12.11B |
| P/E Ratio | 20.58 |
| Forward P/E | — |
| EPS | $1.55 |
| Revenue TTM | $1.6B |
| Dividend Yield | 0.00% |
| Beta | 0.6 |
| Volume | 517.75K |
| 52-week range | $92.77-$127.99 |
| RSI 14 | 49.17 |
| 50-Day SMA | $115.26 |
| 200-Day SMA | $107.23 |
| Analyst Price Target | $148.20 |
| Next Earnings | Oct 28, 2026 |
Create a free account to keep researching stocks
You have viewed 2 stock pages in the last 24 hours. Create a free account to keep researching current evidence.
EHC
OverviewEHC Stock Analysis Summary
Encompass Health Corporation (EHC) currently has an AIQ Score of 62/100, indicating a neutral setup. Quality is the strongest factor at 69/100. Value is the weakest current factor at 57/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, EHC has AIQ Score of 62/100 with Quality base of 69/100 and fading Value at 57/100. Wait for component alignment before adding exposure.
Healthcare · -0.65% stock move · EHC classified in Medical - Care Facilities.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is EHC Bullish or Bearish Right Now?
EHC currently has a neutral overall setup. Quality is the strongest factor at 69/100, while Value is weakest at 57/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 69/100.
- - Momentum is constructive at 60/100.
- - Risk Resilience is supportive at 60/100.
- - Price is +5.66% above its 50-day SMA.
- - Analyst target implies +21.68% upside from the latest quote.
- - No strong bearish evidence is available in the current snapshot.
Current Consensus
EHC's Technical Analysis Consensus is currently Buy, with 28 buy, 8 neutral, and 9 sell votes. EHC's 14-day RSI is 49.17, which places the stock in a neutral momentum range. EHC's beta is 0.6, indicating lower market sensitivity than the broad market.
What Changed in EHC?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the EHC Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
EHC Decision Framework
Public evidence layers, setup checks, and risk context for Encompass Health Corporation.
Encompass Health Corporation (EHC) Stock Analysis
Encompass Health Corporation has an AIQ Score of 62/100 in a Neutral regime. Quality is strongest at 69/100. Beta is 0.6, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | EHC is in a Neutral AIQ regime with score 62/100. |
| Signal Conflict | The primary conflict is that quality leads at 69/100 while value lags at 57/100. |
| Factor Evidence | Momentum 60/100 · Value 57/100 · Quality 69/100 · Risk 60/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Quality is the strongest factor at 69/100.
Momentum is 60/100 and RSI (14) is 49.2.
EHC is in a Neutral regime at 62/100.
Risk factor is 60/100 with beta 0.6 and annual volatility 28.78%.
Current conflict: quality leads at 69/100 while value lags at 57/100.
EHC Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
EHC Fundamentals
EHC valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
EHC Technical Analysis
EHC technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
EHC Stock Catalysts
Track EHC earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
EHC Dividend Analysis
EHC dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
EHC Financial Data
EHC revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
EHC Risk Analysis
EHC volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
EHC Stock News
EHC stock news, market tone, recent headlines, and catalyst context.
EHC vs Healthcare Services / Managed Care Peers
Current peer cohort: EHC · ELV · HCA · HCAT · HIMS. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| EHC Current stock | 62/100 | 57/100 | 60/100 | 60/100 | -0.07 | 28.78% | Current |
| ELV Elevance Health | 64/100 | 68/100 | 77/100 | 66/100 | 0.87 | 35.13% | EHC vs ELV |
| HCA HCA Healthcare | 52/100 | 67/100 | 47/100 | 45/100 | -0.03 | 30.78% | EHC vs HCA |
| HCAT Health Catalyst | 46/100 | 73/100 | 41/100 | 39/100 | -0.36 | 90.01% | EHC vs HCAT |
| HIMS Hims & Hers Health | 39/100 | 58/100 | 39/100 | 19/100 | -0.19 | 93.28% | EHC vs HIMS |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 5, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 6, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching EHC
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for EHC
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
EHC Stock FAQ
What is EHC stock price today?
Encompass Health Corporation's current stock price is $121.79. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is EHC bullish or bearish right now?
EHC's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is EHC's market cap?
EHC's market cap is $12.11B based on the latest completed market-close snapshot from Sep 4, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is EHC's current P/E ratio?
EHC's current P/E ratio is 20.58 based on the latest completed market-close snapshot from Sep 4, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is EHC's RSI?
EHC's 14-day RSI is 49.17 based on the latest completed market-close snapshot from Sep 4, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is EHC above its 50-day and 200-day moving averages?
EHC is 5.66% from its 50-day SMA and 13.58% from its 200-day SMA based on the latest completed market-close snapshot from Sep 4, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is EHC's next earnings date?
EHC's next earnings date is currently listed as Oct 28, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does EHC pay a dividend?
EHC's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 4, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.